On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Vaccines will address challenges of 21st century
- Aging society
- Causes of increased average life expectancy
- Increased life expectancy due to less diseases
- Pasteur started the greatest revolution in history
- Life expectancy is growing beyond prediction
- HIV - example of the impact of infectious diseases
- Vaccination is the most effective treatment
- Future vaccination will be for all ages
- New tech. increased vaccine targets and safety
- Safety of vaccines increased in the 21st century
- Vaccines developed following Pasteur principles
- Safety concerns about crude preparations
- Vaccines with safety concerns were discontinued
- Increased vaccine safety
- Types of novel technologies of vaccines
- Meningococcal disease (1)
- Meningococcal disease (2)
- N. meningitidis has many serotypes
- Glycoconjugation improves the immunogenicity
- Conjugate vaccines for meningococcus C
- A self antigen cannot be used for vaccination
- No success for developing a vaccine for MenB
- OMV was successful to eliminate epidemic in NZ
- Genomics and "reverse vaccinology"
- 3 main antigens included in a vaccine
- A vaccine able to induce antibodies in vitro
- Reverse vaccinology improves targeting
- Vaccines are the response to antibiotic resistance
- Many cancers can be prevented
- New vaccines will address health of aging society
- Emerging infections
- The evolution of the H1 Hemagglutinin sequence
- A vaccine against avian influenza, H5N1
- MF59: established adjuvant in a licensed vaccine
- Vaccinating with clade 1 H5N1 after clade 0
- Memory T cells induced first, B are more abundant
- The H5N1 pandemic prepared us to face H1N1
- Poverty
- Vaccines to address poverty
- Addressing the gaps in vaccine development
- Novartis Vaccines Institute for Global Health
- Combination conjugate Salmonella vaccines
- Vaccines in the 21st century
Topics Covered
- Major health challenges of the 21st Century
- Causes of increased life expectancy: conquest of infectious diseases
- Life expectancy is growing beyond prediction
- New technologies in the last 30 years
- Safety of vaccines
- Meningococcal disease
- Vaccines for Meningococcus C
- Meningococcus B
- Reverse vaccinology allows us to target many pathogens that were difficult or impossible before
- Prevention of cancers
- Vaccination and our aging society
- H5N1 vaccine
- Vaccines to address poverty
- Novartis Vaccines Institute for Global Health
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Rappuoli, R. (2011, August 31). Vaccines: a health insurance of the 21st century [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/CUIP6899.Export Citation (RIS)
Publication History
- Published on August 31, 2011
Financial Disclosures
- Prof. Rino Rappuoli has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.